연구 전 3개월 이내에 당화혈색소 수치가 10% 미만이었고 위장관 증상과 관련된 약물에는 변화가 없었다.
Within the 3 months preceding the study, glycosylated hemoglobin level was lower than 10%, and the medication associated with GI symptoms was unchanged.